1
The chronic use of oral corticosteroids (OCS) has detrimental consequences for health outcomes, productivity, life expectancy, and health care costs among patients with asthma, according to a study in the Journal of Allergy and Clinical Immunology: Global.1
“Asthma affects over 25 million people in the United States, with asthma-related health care costs estimated at almost $82 billion annually; these costs are predicted to grow in the future, in particular if the prevalence of uncontrolled asthma does not improve,” according to authors of the study. “The Global Initiative for Asthma guidelines recommend limiting OCS use and now recommend…